MetaADEDB 2.0 @ LMMD
Hydrogen Peroxide
(MHAJPDPJQMAIIY-UHFFFAOYSA-N)
Structure
SMILES
OO
Type(s)
Approved; Vet_approved
ATC code(s)
A01AB02; D08AX01; D11AX25; S02AA06
Molecular Formula:
H2O2
Molecular Weight:
34.015
Log P:
0.0174
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
2
TPSA:
40.46
CAS Number(s):
7722-84-1; 8007-30-5
Synonym(s)
1.
Hydrogen Peroxide
2.
Hydrogen Peroxide (H2O2)
3.
Hydroperoxide
4.
Oxydol
5.
Perhydrol
6.
Superoxol
7.
Peroxide, Hydrogen
External Link(s)
MeSHD006861
PubChem Compound784
22326046
ChEBI16240
CHEMBLCHEMBL71595
DrugBankDB11091
DrugCentral3281
KEGGcpd:C00027
dr:D00008
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 33US FAERS
2Product complaintFAERS: 26US FAERS
3Application site painFAERS: 15US FAERS
4Swelling of eyelidFAERS: 14US FAERS
5Application site erythemaFAERS: 11US FAERS
6ScabFAERS: 11US FAERS
7ErythemaFAERS: 10
Canada Vigilance: 1		Canada Vigilance
US FAERS
8PainFAERS: 10US FAERS
9Chemical injuryFAERS: 6US FAERS
10Accidental exposure to productFAERS: 5US FAERS
11Accidental exposureFAERS: 5US FAERS
12Application site burnFAERS: 5US FAERS
13Application site scarFAERS: 5US FAERS
14Application site ulcerFAERS: 5US FAERS
15Incorrect route of drug administrationFAERS: 5US FAERS
16Pharmaceutical product complaintFAERS: 5US FAERS
17Post inflammatory pigmentation changeFAERS: 5US FAERS
18Application site inflammationFAERS: 4US FAERS
19Product quality issueFAERS: 4US FAERS
20SwellingFAERS: 4US FAERS
21VomitingFAERS: 4US FAERS
22Abdominal PainFAERS: 3US FAERS
23ChokingFAERS: 3US FAERS
24Eye irritationFAERS: 3
Canada Vigilance: 2		Canada Vigilance
US FAERS
25Foaming at mouthFAERS: 3US FAERS
26Gingival blisterFAERS: 3US FAERS
27Suicide attemptFAERS: 3US FAERS
28AgeusiaFAERS: 2US FAERS
29Air EmbolismFAERS: 2US FAERS
30Application site discomfortFAERS: 2US FAERS
31Application site irritationFAERS: 2US FAERS
32Application site necrosisFAERS: 2US FAERS
33Application site scabFAERS: 2US FAERS
34Application site swellingFAERS: 2US FAERS
35Application site vesiclesFAERS: 2US FAERS
36Burning sensationFAERS: 2US FAERS
37Chemical burn of gastrointestinal tractFAERS: 2US FAERS
38Drug toxicityFAERS: 2US FAERS
39Facial PainFAERS: 2US FAERS
40FrostbiteFAERS: 2US FAERS
41Gingival erythemaFAERS: 2US FAERS
42HeadacheFAERS: 2US FAERS
43HypophagiaFAERS: 2US FAERS
44Incorrect product administration durationFAERS: 2US FAERS
45Intentional drug misuseFAERS: 2US FAERS
46Medication ErrorFAERS: 2US FAERS
47PruritusFAERS: 2
Canada Vigilance: 1		Canada Vigilance
US FAERS
48RetchingFAERS: 2US FAERS
49Subcutaneous EmphysemaFAERS: 2US FAERS
50Thermal burnFAERS: 2US FAERS
51Throat irritationFAERS: 2US FAERS
52ToothacheFAERS: 2US FAERS
53UlcerFAERS: 2US FAERS
54Unevaluable eventFAERS: 2US FAERS
55Visual ImpairmentFAERS: 2US FAERS
56Abdominal discomfortFAERS: 1US FAERS
57Administration site indentationFAERS: 1US FAERS
58AphagiaFAERS: 1US FAERS
59Application site dischargeFAERS: 1US FAERS
60Application site infectionFAERS: 1US FAERS
61Application site maculeFAERS: 1US FAERS
62Application site plaqueFAERS: 1US FAERS
63Application site reactionFAERS: 1US FAERS
64ArthritisFAERS: 1US FAERS
65AstheniaFAERS: 1US FAERS
66Back PainFAERS: 1US FAERS
67BursitisFAERS: 1US FAERS
68Caustic injuryFAERS: 1US FAERS
69Chest discomfortFAERS: 1US FAERS
70Depressed Level of ConsciousnessFAERS: 1US FAERS
71DiscomfortFAERS: 1US FAERS
72Drug administration errorFAERS: 1US FAERS
73Drug dispensing errorFAERS: 1US FAERS
74DysuriaFAERS: 1US FAERS
75Enamel anomalyFAERS: 1US FAERS
76GastritisFAERS: 1US FAERS
77HypersensitivityFAERS: 1US FAERS
78Incorrect dose administeredFAERS: 1US FAERS
79InflammationFAERS: 122081883CTD
US FAERS
80MaculeFAERS: 1US FAERS
81Medication residueFAERS: 1US FAERS
82MyoclonusFAERS: 1US FAERS
83NauseaFAERS: 1US FAERS
84Neck PainFAERS: 1US FAERS
85NeuritisFAERS: 1US FAERS
86Nonspecific reactionFAERS: 1US FAERS
87Oral mucosal exfoliationFAERS: 1US FAERS
88Oral painFAERS: 1US FAERS
89Oropharyngeal blisteringFAERS: 1US FAERS
90OverdoseFAERS: 1US FAERS
91Periorbital swellingFAERS: 1US FAERS
92Portal venous gasFAERS: 1US FAERS
93ProctitisFAERS: 1US FAERS
94Product closure issueFAERS: 1US FAERS
95Product measured potency issueFAERS: 1US FAERS
96ScreamingFAERS: 1US FAERS
97Skin UlcerFAERS: 1US FAERS
98Skin lesionFAERS: 1US FAERS
99Therapeutic response delayedFAERS: 1US FAERS
100Toxicity to various agentsFAERS: 1US FAERS
101Urinary IncontinenceFAERS: 1US FAERS
102UrticariaFAERS: 1US FAERS
103VasculitisFAERS: 1US FAERS
104Wrong drug administeredFAERS: 1US FAERS
105skin abrasionFAERS: 1US FAERS
106AngioedemaCanada Vigilance: 1Canada Vigilance
107BlepharitisCanada Vigilance: 1Canada Vigilance
108BlindnessCanada Vigilance: 1Canada Vigilance
109Cardiovascular Diseases16936243CTD
110Cataract21377462CTD
111Chemical and Drug Induced Liver Injury16924418
23220588		CTD
112Chemical burns of eyeCanada Vigilance: 1Canada Vigilance
113Chromosome Aberrations22539617CTD
114Chromosome Breakage

View details

20575081
20589741
21543585
22902249
24987704
26231820
27634759
30019796
 		CTD
115Colonic Neoplasms17192441CTD
116Dental Pulp Necrosis23318726CTD
117Diabetes Mellitus, Experimental14563825CTD
118Dyslipidemias21439360CTD
119Echinococcosis21365454CTD
120Eye BurnsCanada Vigilance: 3Canada Vigilance
121Eye inflammationCanada Vigilance: 1Canada Vigilance
122Eye painCanada Vigilance: 4Canada Vigilance
123Fatty Liver10860543CTD
124Fibrosis19458120CTD
125Heart Diseases8869666CTD
126Hyperemia10792963CTD
127Hypertrophy26766292CTD
128Hypoxia23270704CTD
129Ischemia19458120CTD
130Kidney Failure, Chronic16518626CTD
131Lens Diseases21139692CTD
132Lung diseases20920717CTD
133Micronuclei, Chromosome-Defective10340725
20575081
24075811		CTD
134Myocardial Ischemia2746659CTD
135Necrosis

View details

10486581
10891466
15191356
16310883
16532269
16863996
19780897
19885844
20525898
21400612
25280774
 		CTD
136Neointima15867141CTD
137Neoplasm Invasiveness21749277
22580338		CTD
138Neoplasm Metastasis12538496
18930813
22580338		CTD
139Nerve Degeneration

View details

10650884
21073519
21820214
23726866
 		CTD
140Neurotoxicity Syndromes23068419CTD
141Papilloma12065085CTD
142PhotophobiaCanada Vigilance: 2Canada Vigilance
143Product label confusionCanada Vigilance: 2Canada Vigilance
144Product label issueCanada Vigilance: 3Canada Vigilance
145Proteinuria1942778CTD
146Reperfusion Injury16682413
19193722		CTD
147Skin Neoplasms12065085CTD
148Spinal Cord Injuries23452429CTD
149Therapeutic product effect decreasedCanada Vigilance: 1Canada Vigilance
150Wounds and Injuries23178681CTD
151melanoma20674559CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.